Showing results (111-120 of 258) with videos related to
Sort By:
Pageof 26
Chembiochem : a European Journal of Chemical Biology|October 27, 2009
Inhibition of HSP90 with pochoximes: SAR and structure-based insightsSofia Barluenga, Jean-Gonzague Fontaine, Cuihua Wang, et al.Journal of the American Chemical Society|September 15, 2005
Hsp90 inhibitors identified from a library of novobiocin analoguesXiao Ming Yu, Gang Shen, Len Neckers, et al.Pharmaceutical Research|September 1, 2005
Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel diseaseHeejung Kim, Hyesik Kong, Boim Choi, et al.Molecular Pharmacology|January 13, 2006
A molecular mechanism for the anti-inflammatory effect of taurine-conjugated 5-aminosalicylic acid in inflamed colonHeejung Kim, Hyunchu Jeon, Hyesik Kong, et al.Methods in Molecular Biology (Clifton, N.J.)|November 28, 2017
Clinical Evaluation and Biomarker Profiling of Hsp90 InhibitorsAkira Yuno, Min-Jung Lee, Sunmin Lee, et al.Current Opinion in Urology|September 16, 2015
Immunotherapies for bladder cancer: a new hopeFarhad Fakhrejahani, Yusuke Tomita, Agnes Maj-Hes, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Curcumin is an inhibitor of p300 histone acetylatransferaseMonica G Marcu, Yun-Jin Jung, Sunmin Lee, et al.Journal of Translational Medicine|July 23, 2015
Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancerJung-Min Lee, Nicolas Gordon, Jane B Trepel, et al.Annual Review of Medicine|January 12, 2010
Molecular diagnosis and therapy of kidney cancerW Marston Linehan, Gennady Bratslavsky, Peter A Pinto, et al.Cell Cycle (Georgetown, Tex.)|August 5, 2008
Low-penetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant rasYoonsoo Park, Akihito Kubo, Takefumi Komiya, et al.Pageof 26